Pancreatic Information

Return to Previous Page

FDA Approves Abraxane for Late-stage Pancreatic Cancer

The U.S. Food and Drug Administration has expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, albumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.

Read More


A Journey Completed

by Alyssa Phillips

My story has a happy ending, but it didn’t exactly start out that way – at all. In order for me to tell you how I got to where I am today and what I learned along the way, I must first tell you where I began.

Read More


Chemotherapy Regimen Extends Survival in Advanced Pancreatic Cancer

A four-drug chemotherapy regimen has produced the longest improvement in survival ever seen in a phase III clinical trial of people with metastatic pancreatic cancer, one of the deadliest types of cancer.

Read More


Coping with the Side Effects of Androgen Deprivation Therapy for Prostate Cancer

by Sylvie Aubin, PhD

Androgen deprivation therapy is a commonly prescribed treatment option for men diagnosed with prostate cancer. It consists of suppressing or stopping the production of male hormones and usually results in a decrease of the prostate-specific antigen, an important marker of cancer activity. Treatment approaches may include surgical removal of testes or drugs administered on a continual or intermittent basis.

Read More


Surprise Finding: Pancreatic Cancers Progress Slowly

Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease.

Read More


Chemotherapy Provides Longer Survival than Enzyme Therapy for Pancreatic Cancer

In a clinical trial testing an experimental enzyme regimen against gemcitabine-based chemotherapy for advanced pancreatic cancer, people receiving chemotherapy lived an average of 9.7 months longer. The results are published in the Journal of Clinical Oncology.

Read More


Exploring Your Options for Pancreatic Cancer Treatment

It is hard to stage pancreatic cancer accurately by imaging tests. Doctors must do their best to decide before surgery whether there is a good chance the cancer can be completely removed. Surgeons usually consider a pancreatic cancer resectable (completely removable by surgery) if it is staged as T1, T2, or T3. That means it doesn’t extend far beyond the pancreas, especially into nearby large blood vessels (T4). There is no accurate way to assess the lymph node spread of the tumor before surgery.

Read More


General Information About Pancreatic Cancer

Pancreatic cancer is a disease in which malignant (cancer) cells form in the tissues of the pancreas. This summary provides information on exocrine pancreatic cancer.

Read More



eUpdate Sign up

Receive e-mails with links to the latest content on the Coping with Cancer website.

See past issues of eUpdate.

Follow us on Twitter

          Twitter icon

Like us on Facebook

          FaceBook icon

Subscribe to
Coping with Cancer magazine